Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.
Clara Odilia SailerOdile GaislSvetlana BeglingerMartina Frech-DörflerVivienne SommerMaya Horst LüthyMirjam Christ-CrainPublished in: European journal of endocrinology (2023)
Our results indicate that of our investigated parameters plasma copeptin ratio is the best predictor for treatment response in children with MNE. Plasma copeptin ratio could thus be useful to identify children with the highest benefit of desmopressin treatment and improve individualized treatment of monosymptomatic nocturnal enuresis.